TY - JOUR
T1 - The evolving role of glycoprotein IIb/IIIa inhibitor therapy in contemporary care of acute coronary syndrome patients
AU - Tricoci, Pierluigi
AU - Peterson, Eric D.
PY - 2006/10
Y1 - 2006/10
N2 - Results from clinical trials of glycoprotein IIb/IIIa(GPIIb/IIIa) inhibitors during the past decade have established their current role in the treatment of non-ST -segment elevation acute coronary syndrome and in percutaneous coronary interventions. However, there are still unanswered questions on optimal use of GPIIb/IIIa inhibitors. Moreover, as new concomitant or alternative medications become available, the role of GPIIb/IIIa inhibitors must be reconsidered. This review discusses, in the light of clinical trials recently presented, what we know, what we are learning, and what we still need to learn.
AB - Results from clinical trials of glycoprotein IIb/IIIa(GPIIb/IIIa) inhibitors during the past decade have established their current role in the treatment of non-ST -segment elevation acute coronary syndrome and in percutaneous coronary interventions. However, there are still unanswered questions on optimal use of GPIIb/IIIa inhibitors. Moreover, as new concomitant or alternative medications become available, the role of GPIIb/IIIa inhibitors must be reconsidered. This review discusses, in the light of clinical trials recently presented, what we know, what we are learning, and what we still need to learn.
UR - http://www.scopus.com/inward/record.url?scp=33749440852&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33749440852&partnerID=8YFLogxK
U2 - 10.1111/j.1540-8183.2006.00182.x
DO - 10.1111/j.1540-8183.2006.00182.x
M3 - Review article
C2 - 17020570
AN - SCOPUS:33749440852
SN - 0896-4327
VL - 19
SP - 449
EP - 455
JO - Journal of Interventional Cardiology
JF - Journal of Interventional Cardiology
IS - 5
ER -